About Thomas DePasquale
Thomas DePasquale is a director at Cerium Pharmaceuticals.
Thomas DePasquale first appears on SEC filings in 2021.
Experience
This experience comes from Thomas DePasquale's profile and from SEC filings. For roles taken from filings, the years are when the filings name Thomas DePasquale in the role, so the role may have started earlier or lasted longer.
Cerium Pharmaceuticals, Inc. Current
Chairperson
2018 – Present · Gaithersburg, MD
Develops medicines for people with kidney diseases.
PI
PawsGlobal, Inc.
Strategic Advisor
2016 – 2024
UV
University of Virginia
Board Member
2016 – 2024
YO
Yopine
Chairman
2014 – 2024
CA
Curb (App)
Chairman/CEO/Founder
2012 – 2014
CO
Concur
Executive Vice President Technology
2006 – 2011
OU
Outtask
President, CEO and Founder
1999 – 2006
PT
Platinum Technology
Executive Vice President
1995 – 1999
RE
Reltech
CEO & President
1988 – 1995
AA
Arthur Andersen
Manager
1982 – 1988
Key Colleagues at Startups
The people Thomas DePasquale works with at each company, as listed on that company's latest Form D.
Cerium Pharmaceuticals, Inc. · Form D, Aug 6, 2026
SE
Steve Eskenazi
Director
PC
Peter Collum
Director
James Gale
Board Member
Gregg Lapointe
Co-Founder, Chief Executive Officer and director
Robert Rubin
Co-Founder, Interim CMO and director